Proliferation activity is significantly elevated in partially embolized cerebral arteriovenous malformations

Cerebrovascular Diseases

Volumn 30, Issue 4, 2010, Pages 396-401

  Sandalcioglu, I Erol ^a,c   Asgari, Siamak ^a   Wende, Doreen ^a   Van De Nes, Johannes A P ^b   Dumitru, Claudia A ^c   Zhu, Yuan ^a   Gizewski, Elke R ^c   Stolke, Dietmar ^a   Sure, Ulrich ^a  

^a Department of Neurosurgery ^*  (Germany)

^b Institute of Neuropathology   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Angiogenesis; Arteriovenous malformation; Cerebral angiomas; Endothelial proliferation

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; CD31 ANTIGEN; CD34 ANTIBODY; KI 67 ANTIGEN; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; ARTIFICIAL EMBOLISM; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN EMBOLISM; BRAIN HEMORRHAGE; CLINICAL FEATURE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEIZURE;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD31; ANTIGENS, CD34; CASE-CONTROL STUDIES; CELL PROLIFERATION; CHILD; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; INTRACRANIAL EMBOLISM; KI-67 ANTIGEN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 77955190677     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319568     Document Type: Article

References (34)

1. Ondra SL, Troupp H, George ED, Schwab K: The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment. J Neurosurg 1990;73:387-391.
2. Brown RD Jr, Wiebers DO, Forbes G, O'Fallon WM, Piepgras DG, Marsh WR, Maciunas RJ: The natural history of unruptured intracranial arteriovenous malformations. J Neurosurg 1988;68:352-357.
3. Hartmann A, Mast H, Mohr JP, Koennecke HC, Osipov A, Pile-Spellman J, Duong DH, Young WL: Morbidity of intracranial hemorrhage in patients with cerebral arteriovenous malformation. Stroke 1998;29:931-934.
4. Mullan S, Mojtahedi S, Johnson DL, Macdonald RL: Embryological basis of some aspects of cerebral vascular fistulas and malformations. J Neurosurg 1996;85:1-8.
5. Spetzler RF, Wilson CB: Enlargement of an arteriovenous malformation documented by angiography: case report. J Neurosurg 1975;43:767-769.
6. Wakabayashi S, Ohno K, Shishido T, Tamaki M, Matsushima Y, Hirakawa K: Marked growth of a cerebral arteriovenous malformation: case report and review of the literature. Neurosurgery 1991;29:920-923.
7. Minakawa T, Tanaka R, Koike T, Takeuchi S, Sasaki O: Angiographic follow-up study of cerebral arteriovenous malformations with reference to their enlargement and regression. Neurosurgery 1989;24:68-74.
8. Mendelow AD, Erfurth A, Grossart K, Macpherson P: Do cerebral arteriovenous malformations increase in size? J Neurol Neurosurg Psychiatry 1987;50:980-987.
9. Friedman JA, Pollock BE, Nichols DA: Development of a cerebral arteriovenous malformation documented in an adult by serial angiography: case report. J Neurosurg 2000;93:1058-1061.
10. Bulsara KR, Alexander MJ, Villavicencio AT, Graffagnino C: De novo cerebral arteriovenous malformation: case report. Neurosurgery 2002;50:1137-1141.
11. Gabriel EM, Sampson JH, Wilkins RH: Recurrence of a cerebral arteriovenous malformation after surgical excision: case report. J Neurosurg 1996;84:879-882.
12. Kader A, Goodrich JT, Sonstein WJ, Stein BM, Carmel PW, Michelsen WJ: Recurrent cerebral arteriovenous malformations after negative postoperative angiograms. J Neurosurg 1996;85:14-18.
13. Lanzino G, Fergus A, Jensen ME, Kassell NF: Recurrence of arteriovenous malformations. J Neurosurg 1996;85:1196-1197.
14. Hashimoto N, Nozaki K: Do cerebral arteriovenous malformations recur after angiographically confirmed total extirpation? Crit Rev Neurosurg 1999;9:141-146.
15. Freudenstein D, Duffner F, Ernemann U, Rachinger J, Grote E: Recurrence of a cerebral arteriovenous malformation after surgical excision. Cerebrovasc Dis 2001;11:59-64.
16. Rothbart D, Awad IA, Lee J, Kim J, Harbaugh R, Criscuolo GR: Expression of angiogenic factors and structural proteins in central nervous system vascular malformations. Neurosurgery 1996;38:915-925.
17. Sonstein WJ, Kader A, Michelsen WJ, Llena JF, Hirano A, Casper D: Expression of vascular endothelial growth factor in pediatric and adult cerebral arteriovenous malformations: an immunocytochemical study. J Neurosurg 1996;85:838-845.
18. Kilic T, Pamir MN, Kullu S, Eren F, Ozek MM, Black PM: Expression of structural proteins and angiogenic factors in cerebrovascular anomalies. Neurosurgery 2000;46:1179-1192.
19. Sure U, Butz N, Siegel AM, Mennel HD, Bien S, Bertalanffy H: Treatment-induced neoangiogenesis in cerebral arteriovenous malformations. Clin Neurol Neurosurg 2001;103:29-32.
20. Sure U, Butz N, Schlegel J, Siegel AM, Wakat JP, Mennel HD, Bien S, Bertalanffy H: Endothelial proliferation, neoangiogenesis, and potential de novo generation of cerebrovascular malformations. J Neurosurg 2001;94:972-977.
21. Koizumi T, Shiraishi T, Hagihara N, Tabuchi K, Hayashi T, Kawano T: Expression of vascular endothelial growth factors and their receptors in and around intracranial arteriovenous malformations. Neurosurgery 2002;50:117-126.
22. Ikeda E, Achen MG, Breier G, Risau W: Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 1995;270:19761-19766.
23. Minchenko A, Bauer T, Salceda S, Caro J: Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab Invest 1994;71:374-379.
24. Marti HJ, Bernaudin M, Bellail A, Schoch H, Euler M, Petit E, Risau W: Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol 2000;156:965-976.
25. Spetzler RF, Martin NA: A proposed grading system for arteriovenous malformations. J Neurosurg 1986;65:476-483.
26. Krayenbuhl HA: Angiographic contribution to the problem of enlargement of cerebral arteriovenous malformations. Acta Neurochir 1977;36:215-242.
27. Delitala A, Delfini R, Vagnozzi R, Esposito S: Increase in size of cerebral angiomas: case report. J Neurosurg 1982;57:556-558.
28. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NP, Risau W, Ullrich A: High affinity VEGF binding and developmental expression suggest flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993;72:835-846.
29. Sure U, Battenberg E, Dempfle A, Tirakotai W, Bien S, Bertalanffy H: Hypoxia-inducible factor and vascular endothelial growth factor are expressed more frequently in embolized than in nonembolized cerebral arteriovenous malformations. Neurosurgery 2004;55:663-670.
30. Sandalcioglu IE, Wende D, Eggert A, Muller D, Roggenbuck U, Gasser T, Wiedemayer H, Stolke D: Vascular endothelial growth factor plasma levels are significantly elevated in patients with cerebral arteriovenous malformations. Cerebrovasc Dis 2006;21:154-158.
31. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody ki-67. J Immunol 1984;133:1710-1715.
32. Chang H, Shyu KG, Wang BW, Kuan P: Regulation of hypoxia-inducible factor-1 - by cyclical mechanical stretch in rat vascular smooth muscle cells. Clin Sci (Lond) 2003;105:447-456.
33. Zhu Y, Lawton MT, Du R, Shwe Y, Chen Y, Shen F, Young WL, Yang GY: Expression of hypoxia-inducible factor-1 and vascular endothelial growth factor in response to venous hypertension. Neurosurgery 2006;59:687-696.
34. Han PP, Ponce FA, Spetzler RF: Intention-totreat analysis of Spetzler-Martin grades IV and V arteriovenous malformations: natural history and treatment paradigm. J Neurosurg 2003;98:3-7.